4-[2-[4-(4-cyclohexyl-4-methoxycyclohexyl)phenyl]imidazo[2,1-b][1,3]thiazol-6-yl]-N-[(3S,6S,9S,11R,15S,18S,20R,24S,25S,26S)-3-[(1R)-3-(1,3-dihydroxypropan-2-ylamino)-1-hydroxypropyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-6-[(1R)-1-hydroxy-2-[4-hydroxy-3-(trioxidanylsulfanyloxy)phenyl]ethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]benzamide

C69H92N10O21S2 — CID 90926716

IUPAC4-[2-[4-(4-cyclohexyl-4-methoxycyclohexyl)phenyl]imidazo[2,1-b][1,3]thiazol-6-yl]-N-[(3S,6S,9S,11R,15S,18S,20R,24S,25S,26S)-3-[(1R)-3-(1,3-dihydroxypropan-2-ylamino)-1-hydroxypropyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-6-[(1R)-1-hydroxy-2-[4-hydroxy-3-(trioxidanylsulfanyloxy)phenyl]ethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]benzamide
SMILESCOC1(C2CCCCC2)CCC(c2ccc(-c3cn4cc(-c5ccc(C(=O)N[C@H]6C[C@@H](O)CNC(=O)[C@@H]7[C@@H](O)[C@@H](C)CN7C(=O)[C@H]([C@H](O)CCNC(CO)CO)NC(=O)[C@H]([C@H](O)Cc7ccc(O)c(OSOOO)c7)NC(=O)[C@@H]7C[C@@H](O)CN7C(=O)[C@H]([C@@H](C)O)NC6=O)cc5)nc4s3)cc2)CC1
InChIInChI=1S/C69H92N10O21S2/c1-36-30-79-59(60(36)88)65(93)71-29-46(83)27-48(72-61(89)43-16-12-41(13-17-43)49-32-77-33-55(101-68(77)73-49)42-14-10-39(11-15-42)40-19-22-69(97-3,23-20-40)44-7-5-4-6-8-44)62(90)74-56(37(2)82)66(94)78-31-47(84)28-50(78)63(91)75-57(53(87)25-38-9-18-51(85)54(26-38)98-102-100-99-96)64(92)76-58(67(79)95)52(86)21-24-70-45(34-80)35-81/h9-18,26,32-33,36-37,40,44-48,50,52-53,56-60,70,80-88,96H,4-8,19-25,27-31,34-35H2,1-3H3,(H,71,93)(H,72,89)(H,74,90)(H,75,91)(H,76,92)/t36-,37+,40?,46+,47+,48-,50-,52+,53+,56-,57-,58-,59-,60-,69?/m0/s1
InChIKeyPTPKQUFUWCYWGB-IAKZEMHQSA-N
MW1461.68 g/mol
LogP0.70
Rot. Bonds22

About 4-[2-[4-(4-cyclohexyl-4-methoxycyclohexyl)phenyl]imidazo[2,1-b][1,3]thiazol-6-yl]-N-[(3S,6S,9S,11R,15S,18S,20R,24S,25S,26S)-3-[(1R)-3-(1,3-dihydroxypropan-2-ylamino)-1-hydroxypropyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-6-[(1R)-1-hydroxy-2-[4-hydroxy-3-(trioxidanylsulfanyloxy)phenyl]ethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]benzamide

4-[2-[4-(4-cyclohexyl-4-methoxycyclohexyl)phenyl]imidazo[2,1-b][1,3]thiazol-6-yl]-N-[(3S,6S,9S,11R,15S,18S,20R,24S,25S,26S)-3-[(1R)-3-(1,3-dihydroxypropan-2-ylamino)-1-hydroxypropyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-6-[(1R)-1-hydroxy-2-[4-hydroxy-3-(trioxidanylsulfanyloxy)phenyl]ethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]benzamide (PubChem CID 90926716) has the molecular formula C69H92N10O21S2 and a molecular weight of 1461.68 g/mol. Its IUPAC name is 4-[2-[4-(4-cyclohexyl-4-methoxycyclohexyl)phenyl]imidazo[2,1-b][1,3]thiazol-6-yl]-N-[(3S,6S,9S,11R,15S,18S,20R,24S,25S,26S)-3-[(1R)-3-(1,3-dihydroxypropan-2-ylamino)-1-hydroxypropyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-6-[(1R)-1-hydroxy-2-[4-hydroxy-3-(trioxidanylsulfanyloxy)phenyl]ethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]benzamide.

Molecular Properties

Compound Name4-[2-[4-(4-cyclohexyl-4-methoxycyclohexyl)phenyl]imidazo[2,1-b][1,3]thiazol-6-yl]-N-[(3S,6S,9S,11R,15S,18S,20R,24S,25S,26S)-3-[(1R)-3-(1,3-dihydroxypropan-2-ylamino)-1-hydroxypropyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-6-[(1R)-1-hydroxy-2-[4-hydroxy-3-(trioxidanylsulfanyloxy)phenyl]ethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]benzamide
PubChem CID90926716
Molecular FormulaC69H92N10O21S2
Molecular Weight1461.68 g/mol
Exact Mass1460.59
IUPAC Name4-[2-[4-(4-cyclohexyl-4-methoxycyclohexyl)phenyl]imidazo[2,1-b][1,3]thiazol-6-yl]-N-[(3S,6S,9S,11R,15S,18S,20R,24S,25S,26S)-3-[(1R)-3-(1,3-dihydroxypropan-2-ylamino)-1-hydroxypropyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-6-[(1R)-1-hydroxy-2-[4-hydroxy-3-(trioxidanylsulfanyloxy)phenyl]ethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]benzamide
SMILESCOC1(C2CCCCC2)CCC(c2ccc(-c3cn4cc(-c5ccc(C(=O)N[C@H]6C[C@@H](O)CNC(=O)[C@@H]7[C@@H](O)[C@@H](C)CN7C(=O)[C@H]([C@H](O)CCNC(CO)CO)NC(=O)[C@H]([C@H](O)Cc7ccc(O)c(OSOOO)c7)NC(=O)[C@@H]7C[C@@H](O)CN7C(=O)[C@H]([C@@H](C)O)NC6=O)cc5)nc4s3)cc2)CC1
InChIInChI=1S/C69H92N10O21S2/c1-36-30-79-59(60(36)88)65(93)71-29-46(83)27-48(72-61(89)43-16-12-41(13-17-43)49-32-77-33-55(101-68(77)73-49)42-14-10-39(11-15-42)40-19-22-69(97-3,23-20-40)44-7-5-4-6-8-44)62(90)74-56(37(2)82)66(94)78-31-47(84)28-50(78)63(91)75-57(53(87)25-38-9-18-51(85)54(26-38)98-102-100-99-96)64(92)76-58(67(79)95)52(86)21-24-70-45(34-80)35-81/h9-18,26,32-33,36-37,40,44-48,50,52-53,56-60,70,80-88,96H,4-8,19-25,27-31,34-35H2,1-3H3,(H,71,93)(H,72,89)(H,74,90)(H,75,91)(H,76,92)/t36-,37+,40?,46+,47+,48-,50-,52+,53+,56-,57-,58-,59-,60-,69?/m0/s1
InChIKeyPTPKQUFUWCYWGB-IAKZEMHQSA-N
XLogP0.70
TPSA454.67 Ų
H-Bond Donors16
H-Bond Acceptors26
Rotatable Bonds22
Heavy Atoms102
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001461.68
LogP ≤ 50.70
H-Bond Donors ≤ 516
H-Bond Acceptors ≤ 1026

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}, {'alert_name': 'peroxide', 'substructure': 'N/A'}, {'alert_name': 'sulfur_oxygen_single_bond', 'substructure': 'N/A'}

Analyze 4-[2-[4-(4-cyclohexyl-4-methoxycyclohexyl)phenyl]imidazo[2,1-b][1,3]thiazol-6-yl]-N-[(3S,6S,9S,11R,15S,18S,20R,24S,25S,26S)-3-[(1R)-3-(1,3-dihydroxypropan-2-ylamino)-1-hydroxypropyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-6-[(1R)-1-hydroxy-2-[4-hydroxy-3-(trioxidanylsulfanyloxy)phenyl]ethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[2-[4-(4-cyclohexyl-4-methoxycyclohexyl)phenyl]imidazo[2,1-b][1,3]thiazol-6-yl]-N-[(3S,6S,9S,11R,15S,18S,20R,24S,25S,26S)-3-[(1R)-3-(1,3-dihydroxypropan-2-ylamino)-1-hydroxypropyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-6-[(1R)-1-hydroxy-2-[4-hydroxy-3-(trioxidanylsulfanyloxy)phenyl]ethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]benzamide?
The IUPAC name of 4-[2-[4-(4-cyclohexyl-4-methoxycyclohexyl)phenyl]imidazo[2,1-b][1,3]thiazol-6-yl]-N-[(3S,6S,9S,11R,15S,18S,20R,24S,25S,26S)-3-[(1R)-3-(1,3-dihydroxypropan-2-ylamino)-1-hydroxypropyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-6-[(1R)-1-hydroxy-2-[4-hydroxy-3-(trioxidanylsulfanyloxy)phenyl]ethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]benzamide (CID 90926716) is 4-[2-[4-(4-cyclohexyl-4-methoxycyclohexyl)phenyl]imidazo[2,1-b][1,3]thiazol-6-yl]-N-[(3S,6S,9S,11R,15S,18S,20R,24S,25S,26S)-3-[(1R)-3-(1,3-dihydroxypropan-2-ylamino)-1-hydroxypropyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-6-[(1R)-1-hydroxy-2-[4-hydroxy-3-(trioxidanylsulfanyloxy)phenyl]ethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]benzamide.
What is the SMILES notation for 4-[2-[4-(4-cyclohexyl-4-methoxycyclohexyl)phenyl]imidazo[2,1-b][1,3]thiazol-6-yl]-N-[(3S,6S,9S,11R,15S,18S,20R,24S,25S,26S)-3-[(1R)-3-(1,3-dihydroxypropan-2-ylamino)-1-hydroxypropyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-6-[(1R)-1-hydroxy-2-[4-hydroxy-3-(trioxidanylsulfanyloxy)phenyl]ethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]benzamide?
The canonical SMILES for 4-[2-[4-(4-cyclohexyl-4-methoxycyclohexyl)phenyl]imidazo[2,1-b][1,3]thiazol-6-yl]-N-[(3S,6S,9S,11R,15S,18S,20R,24S,25S,26S)-3-[(1R)-3-(1,3-dihydroxypropan-2-ylamino)-1-hydroxypropyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-6-[(1R)-1-hydroxy-2-[4-hydroxy-3-(trioxidanylsulfanyloxy)phenyl]ethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]benzamide is COC1(C2CCCCC2)CCC(c2ccc(-c3cn4cc(-c5ccc(C(=O)N[C@H]6C[C@@H](O)CNC(=O)[C@@H]7[C@@H](O)[C@@H](C)CN7C(=O)[C@H]([C@H](O)CCNC(CO)CO)NC(=O)[C@H]([C@H](O)Cc7ccc(O)c(OSOOO)c7)NC(=O)[C@@H]7C[C@@H](O)CN7C(=O)[C@H]([C@@H](C)O)NC6=O)cc5)nc4s3)cc2)CC1.
What is the InChIKey of 4-[2-[4-(4-cyclohexyl-4-methoxycyclohexyl)phenyl]imidazo[2,1-b][1,3]thiazol-6-yl]-N-[(3S,6S,9S,11R,15S,18S,20R,24S,25S,26S)-3-[(1R)-3-(1,3-dihydroxypropan-2-ylamino)-1-hydroxypropyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-6-[(1R)-1-hydroxy-2-[4-hydroxy-3-(trioxidanylsulfanyloxy)phenyl]ethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]benzamide?
The InChIKey is PTPKQUFUWCYWGB-IAKZEMHQSA-N. The full InChI is InChI=1S/C69H92N10O21S2/c1-36-30-79-59(60(36)88)65(93)71-29-46(83)27-48(72-61(89)43-16-12-41(13-17-43)49-32-77-33-55(101-68(77)73-49)42-14-10-39(11-15-42)40-19-22-69(97-3,23-20-40)44-7-5-4-6-8-44)62(90)74-56(37(2)82)66(94)78-31-47(84)28-50(78)63(91)75-57(53(87)25-38-9-18-51(85)54(26-38)98-102-100-99-96)64(92)76-58(67(79)95)52(86)21-24-70-45(34-80)35-81/h9-18,26,32-33,36-37,40,44-48,50,52-53,56-60,70,80-88,96H,4-8,19-25,27-31,34-35H2,1-3H3,(H,71,93)(H,72,89)(H,74,90)(H,75,91)(H,76,92)/t36-,37+,40?,46+,47+,48-,50-,52+,53+,56-,57-,58-,59-,60-,69?/m0/s1.
What are the key properties of 4-[2-[4-(4-cyclohexyl-4-methoxycyclohexyl)phenyl]imidazo[2,1-b][1,3]thiazol-6-yl]-N-[(3S,6S,9S,11R,15S,18S,20R,24S,25S,26S)-3-[(1R)-3-(1,3-dihydroxypropan-2-ylamino)-1-hydroxypropyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-6-[(1R)-1-hydroxy-2-[4-hydroxy-3-(trioxidanylsulfanyloxy)phenyl]ethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]benzamide?
4-[2-[4-(4-cyclohexyl-4-methoxycyclohexyl)phenyl]imidazo[2,1-b][1,3]thiazol-6-yl]-N-[(3S,6S,9S,11R,15S,18S,20R,24S,25S,26S)-3-[(1R)-3-(1,3-dihydroxypropan-2-ylamino)-1-hydroxypropyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-6-[(1R)-1-hydroxy-2-[4-hydroxy-3-(trioxidanylsulfanyloxy)phenyl]ethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]benzamide has a molecular weight of 1461.68 g/mol, XLogP of 0.70, 22 rotatable bonds, 16 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[2-[4-(4-cyclohexyl-4-methoxycyclohexyl)phenyl]imidazo[2,1-b][1,3]thiazol-6-yl]-N-[(3S,6S,9S,11R,15S,18S,20R,24S,25S,26S)-3-[(1R)-3-(1,3-dihydroxypropan-2-ylamino)-1-hydroxypropyl]-11,20,25-trihydroxy-15-[(1R)-1-hydroxyethyl]-6-[(1R)-1-hydroxy-2-[4-hydroxy-3-(trioxidanylsulfanyloxy)phenyl]ethyl]-26-methyl-2,5,8,14,17,23-hexaoxo-1,4,7,13,16,22-hexazatricyclo[22.3.0.09,13]heptacosan-18-yl]benzamide is sourced from PubChem (CID 90926716), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).